UK Venture Capital Firm Appoints Omobola Johnson Lead Partner In West African Operations

A London-based venture capital firm, TLcom, has appointed former Minister of Communications and Technology, Omobola Johnson, as lead partner as it kicks off its West African operations. The company, which opened its first Africa office in Nairobi, Kenya, two years ago, is ramping up its investment in African start-ups through its TLcom TIDE (Technology and Innovation for Developing Economies) Africa Fund which could see it raise as much as $100 million.

The focus of the investments, which could range from $500,000 to $10 million, will be on e-commerce, energy, health and education technology startups which have a potential for fast growth. In Johnson, TLcom has a partner with a track record and understanding of the technology space in the region. In her four years in government, the tech ecosystem in Nigeria grew fast and she was keen to encourage and enable the growth of local start-ups.

One of her lasting legacies was launching Idea Nigeria, an incubation hub in the heart of Yaba – the epicenter of the tech ecosystem in Lagos. Since leaving office after March/April elections, Johnson has remained on the public radar, and earlier this month, she was announced as Honorary Chairperson of Alliance for Affordable Internet. Maurizio Caio, TLcom founder, said the focus for the Africa Fund would immediately be on start-ups with high returns potential. “For this cycle, we need to be very merciless in focusing on the highest potential entrepreneurs—to make a point and to demonstrate that high returns are possible,” he said. TLcom’s aggressive expansion in search of more tech opportunities in Africa could be a signal fears of investing in African tech companies and achieving profitable exits is abating. Caio said the bigger issue is identifying start-ups with real potential.
“If you have a good company, you can exit. It is a not an exit problem—it is a quality of company problem,” he added.

Source: ThisDay


Please enter your comment!
Please enter your name here